Endovascular
Techniques and Lesion Subsets Learning Series
Pulmonary Embolism and Hypertension Therapies
Advertisement
Episodes
Case 3: High Risk Intermediate PE With Iliocaval DVT
33 min.
Case 2: Neurosurgical Patient With High Risk Intermediate PE
27 min.
Case 1: Massive PE With Shock
30 min.
tate of the Art Lecture: PE New Devices and Catheters: What Will Be New in 2024?
13 min.
Catheter Interventions for Pulmonary Embolism: Clinical Trial Update
10 min.
Modeling the RV Through HARVI
20 min.
Advances in RV Assessment Through TTE
10 min.
New Risk Stratification Tools: AI, Biomarkers, Invasive Hemodynamics, etc.
10 min.
What Skills Are Needed to Start a Balloon Pulmonary Angioplasty Program?
9 min.
Institutional Multidisciplinary Approach to Chronic Thromboembolic Pulmonary Hypertension (CTEPH)
13 min.
How to Establish an Effective Post-PE Pathway
8 min.
Complications With Catheter Therapy
17 min.
Catheter Thrombectomy 101: Tips, Tricks, and Pitfalls, Small Bore and Large Bore
8 min.
Why Should a Cardiologist Care About Pulmonary Embolism?
9 min.
Catheter-Directed Thrombolysis: Protocols, Duration, etc
8 min.
Invasive Hemodynamic Assessment in the Pulmonary Embolism
11 min.
Debate: Intermediate-Risk Pulmonary Embolism — No Data for Catheters, Stick With Heparin!
8 min.
Debate: Intermediate-Risk Pulmonary Embolism – Catheter Thrombectomy Is Best
7 min.
Debate: Intermediate-Risk Pulmonary Embolism – Catheter-directed Thrombolysis as the Primary Option
9 min.
Debate: High-risk Pulmonary Embolism – Surgery Is the Way
14 min.
Debate: High-risk Pulmonary Embolism – Catheter Therapy First in the Modern Era
8 min.
Debate: High-risk Pulmonary Embolism – Systemic Thrombolysis Is Still the Gold Standard
8 min.
PE Risk Stratification in 2023
11 min.
Keynote Lecture: Advances in Interventional Treatment of Pulmonary and Right Heart Thrombosis
14 min.
Intelligent Interventions: Personalized Medicine for VTEs (FlowMedical)
11 min.
PFO PRIMER: Updates and Spotlights – Technology and Techniques: Difficult Cases
6 min.
Real World Experience of Contemporary Pulmonary Embolism Treatment (USCDT versus MT): Insights From Big Data Analytics (REAL-PE)
18 min.
Pulmonary Artery Denervation: Innovative Pulmonary Hypertension Therapies
9 min.
BPA in CTEPH Management
10 min.
Catheter-Based Management of Infectious Endocarditis
8 min.
CTEPH? CTED? How Do We Make the Diagnosis?
9 min.
Anticoagulation for PE: When to Switch to DOACs?
6 min.
Getting Smart With PE Diagnosis: The Role of AI
8 min.
The PERT Effect: How to Establish a Multdisciplinary Care Team for PE
8 min.
State-of-the-Art Lecture: Future Device Therapies in PE
12 min.
What Do the Clinical Trials Tell Us to Do in Intermediate-Risk PE?
10 min.
Large Bore Thrombectomy: Are We Any Closer to Understanding Which Device Is Best?
10 min.
Catheter Directed Thrombolysis: New Devices, Drugs, and Duration?
10 min.
Intermediate-Risk PE Case (NewYork-Presbyterian/Columbia University Irving Medical Center): Case Intro
2 min.
Massive PE Case (NewYork-Presbyterian/Columbia University Irving Medical Center): Case Conclusion
3 min.
TCT 694: Debulking Tricuspid Valve Vegetations: Using AngioVac to Avoid Reoperations for Prosthetic Valve Endocarditis
6 min.
Iliocaval Stenting and Reconstructions With Extreme Case Examples
12 min.
R Sided Clot in Transit
9 min.
BPA for CTEPH: When and How?
10 min.
Anticoagulation Strategies in High-Risk PE: Are DOACs Enough? When Do We Switch?
8 min.
Is There a Role for MCS in Massive PE and Which Modality?
8 min.
Surgical Embolectomy Is the Way to Go in High-Risk PE
7 min.
Who Gets Systemic Thrombolysis Anymore?
9 min.
High-Risk PE Case (NewYork-Presbyterian/Columbia University Irving Medical Center): Case Introduction
2 min.
Aspiration Thrombectomy: a Potential Treatment for Pulmonary Embolism in COVID-19
5 min.
The immediate change in cardiac and hemodynamic physiology following catheter-directed alleviation of intermediate high-risk pulmonary embolism
5 min.
FlowTriever Thrombectomy for “Intermediate Risk” Pulmonary Embolism in a Jehovah’s Witness Patient
5 min.
Case : Emergent thrombectomy in PE with shock
5 min.
Innovation in Interventional PE Therapies
9 min.
Case 2: COVID Patient With Clot in Transit
7 min.
Case 1: Catastrophic PE With Shock
7 min.
Catheter-Based Thrombus Extraction Using Electro-Magnetic Fields (Magneto eTrieve™)
7 min.